Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Features

Features
Serevent warning focuses attention on the need for combination therapy

10 Dec 04

The recent announcement by the FDA's associate director for science and medicine that sales of GlaxoSmithKline's asthma drug Serevent should be restricted, or halted, led to an estimated 3.8% fall in the company's share price. However, Datamonitor's Laura Harris comments that, with Seretide accounting for the majority of GSK's asthma sales, the panic may be premature.
Datamonitor

Drug Discovery Technology Europe 2005

09 Dec 04

Distinct, original scientific and business content focusing on R&D productivity presented by an international line-up of industry experts. Drug Discovery Technology® Europe is known for its high standard of speakers and coherent case studies, which guarantee that delegates grasp an understanding of the pressing issues that affect their industry. This year, for the first time, the conference will be co-located with two other events, InfoTechPharma® 2005 and PharmaSolutions Expo.
Charlotte Hayes

InfoTechPharma 2005

09 Dec 04

The premier annual global forum for top-level Pharma IT executives, examining innovative IT systems and applications to support and accelerate R&D. This exciting programme is the result of research with well over 100 industry professionals and the InfoTechPharma® scientific advisory board. The programme contains only original content tackling key subjects that are currently impacting R&D in pharma and biotech. The format of this years conference will provide an environment that will facilitate i
Charlotte Hayes

PharmaSolutions Expo

09 Dec 04

PharmaSolutions Expo is a unique event gathering the drug discovery, drug development and informatics communities under one roof. Meet face-to-face with solution providers and make comparisons of new technologies. This exhibition will showcase the latest tools and solutions for R&D scientists and Pharma IT professionals. Free exhibition features include: dedicated poster areas and “meet the author” poster sessions, free seminars, lunchtime roundtable discussion groups, biotech start-up presentat
Charlotte Hayes

Freedman takes snapshot of current marketing challenges at eyeforpharma workshop

09 Dec 04

Now, more than ever, pharma marketing operations are being required to demonstrate that they are adding value and delivering measurable return on investment. With this in mind, Freedman International surveyed delegates who attended the eyeforpharma ‘Marketing ROI for Pharma’ conference using a unique self-assessment tool to find out, “How do you fare in terms of the overall effectiveness of your marketing operations?”
Matt Adcock

Arava: the 'sixth drug' that may soon be under fire

08 Dec 04

At a recent hearing into the Vioxx affair, the FDA's Dr David Graham named five drugs that he considers too dangerous to be on the market. However, in his testimony, Dr Graham also cited Sanofi-Aventis' Arava as a drug he has recommended be withdrawn. Unlike the other five drugs, Arava has largely escaped the media spotlight, but there may yet be some tough questions asked about its safety.
Datamonitor

Is image everything?

07 Dec 04

Given the contribution of drugs to advances in healthcare it often comes as a surprise to those in the pharmaceutical sector that the industry’s public image is so poor.
Dr Faiz Kermani

EmTech 5-6 April 2005

30 Nov 04

The conference will present the latest research and advances on new techniques in drug discovery. As well as presentations from some of the top authorities in the field, the exhibition will allow you to view the latest technologies from leading suppliers within the industry. An unmissable event for those wishing to keep abreast of new developments.
Natalie Bell

Free analysis: 'Barriers, best practices and measuring ROI for patient compliance programmes'

29 Nov 04

Unique intelligence from eyeforpharma: 'Barriers, best practices and measuring ROI for patient compliance programmes'
Izzy Wakeling

Tigecycline offers new hope in the battle against MRSA

26 Nov 04

Study data presented at a major recent conference has demonstrated that Wyeth's novel antibacterial tigecycline acts against drug-resistant pathogens in some serious bacterial infections, including MRSA. While Wyeth will have to work hard to establish tigecycline in this competitive area, its encouraging tolerability profile could give it a useful advantage over existing treatments.
Datamonitor

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.